RETRACTED ARTICLE: A randomized phase II study of everolimus for advanced pancreatic neuroendocrine tumors in Chinese patients

Jun Yao, Jian-yao Wang, Yi Liu, Bin Wang, Ying-xue Li, Ru Zhang, Li-Sheng Wang, Lei Liu

Open source

DOI
10.1007/s12032-014-0251-x
Published
2014-11-14
Container
Medical Oncology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12032-014-0251-x,
  title = {RETRACTED ARTICLE: A randomized phase II study of everolimus for advanced pancreatic neuroendocrine tumors in Chinese patients},
  author = {Jun Yao and Jian-yao Wang and Yi Liu and Bin Wang and Ying-xue Li and Ru Zhang and Li-Sheng Wang and Lei Liu},
  year = {2014},
  journal = {Medical Oncology},
  doi = {10.1007/s12032-014-0251-x},
  url = {https://doi.org/10.1007/s12032-014-0251-x}
}

RIS

TY  - JOUR
TI  - RETRACTED ARTICLE: A randomized phase II study of everolimus for advanced pancreatic neuroendocrine tumors in Chinese patients
AU  - Jun Yao
AU  - Jian-yao Wang
AU  - Yi Liu
AU  - Bin Wang
AU  - Ying-xue Li
AU  - Ru Zhang
AU  - Li-Sheng Wang
AU  - Lei Liu
PY  - 2014
JO  - Medical Oncology
DO  - 10.1007/s12032-014-0251-x
UR  - https://doi.org/10.1007/s12032-014-0251-x
ER  - 

APA

Yao, J., Wang, J., Liu, Y., Wang, B., Li, Y., Zhang, R., Wang, L., & Liu, L. (2014). RETRACTED ARTICLE: A randomized phase II study of everolimus for advanced pancreatic neuroendocrine tumors in Chinese patients. Medical Oncology. https://doi.org/10.1007/s12032-014-0251-x

Source records